首页 › 基金 › CONWAY CAPITAL MANAGEMENT, INC. › BSX
CONWAY CAPITAL MANAGEMENT, INC. 对 BSX 的持仓历史
BOSTON SCIENTIFIC CORP · 医疗保健
CONWAY CAPITAL MANAGEMENT, INC. 在 Q3 2026 的 13F 申报中披露持有 BSX(BOSTON SCIENTIFIC CORP)26,600 股,市值约 US$1.2M,约占其申报组合的 0.49%,在其申报持仓中市值排名第 24 位。 CONWAY CAPITAL MANAGEMENT, INC. 最近 13 个申报季度中有 13 个季度披露了 BSX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
CONWAY CAPITAL MANAGEMENT, INC. 对 BSX 的持仓演变
CONWAY CAPITAL MANAGEMENT, INC. 于 Q3 2023 首次披露 BSX 持仓:34,015 股(约 US$1.8M)。 该持仓在 Q2 2025 达到峰值 29,645 股,市值约 US$3.2M。 在 13 次申报中,CONWAY CAPITAL MANAGEMENT, INC. 0 次增持、7 次减持、5 次保持不变。 最近一期申报(Q3 2026)显示持股 26,600 股、市值约 US$1.2M,环比减持 -2,150 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 34.02K | $1.80M | 新进 |
| Q4 2023 | 31.93K | $1.85M | 减持 |
| Q1 2024 | 31.93K | $2.19M | 持有 |
| Q2 2024 | 31.93K | $2.46M | 持有 |
| Q3 2024 | 31.93K | $2.68M | 持有 |
| Q4 2024 | 31.93K | $2.85M | 持有 |
| Q1 2025 | 31.37K | $3.16M | 减持 |
| Q2 2025 | 29.64K | $3.18M | 减持 |
| Q3 2025 | 29.64K | $2.89M | 持有 |
| Q4 2025 | 29.39K | $2.80M | 减持 |
| Q1 2026 | 28.90K | $1.81M | 减持 |
| Q2 2026 | 28.75K | $1.23M | 减持 |
| Q3 2026 | 26.60K | $1.16M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BSX 与 13F 数据
BSX(BOSTON SCIENTIFIC CORP)属于医疗保健行业。我们追踪的基金中还有 18 只申报持有 BSX,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS 投资管理 (US$2.29B), 德劭基金 (US$1.16B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BSX 的基金
- PRIMECAP MANAGEMENT CO/CA/ 58.62M 股 · $2.56B · Q3 2026
- MFS 投资管理 43.05M 股 · $2.29B · Q3 2026
- 德劭基金 27.27M 股 · $1.16B · Q2 2026
- 骏利亨德森集团 16.50M 股 · $1.04B · Q1 2026
- Arrowstreet 资本 23.29M 股 · $994.18M · Q2 2026
更多关于 CONWAY CAPITAL MANAGEMENT, INC.
常见问题
How long has CONWAY CAPITAL MANAGEMENT, INC. held BSX?
CONWAY CAPITAL MANAGEMENT, INC. has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is CONWAY CAPITAL MANAGEMENT, INC.'s current position in BSX?
As of Q3 2026, CONWAY CAPITAL MANAGEMENT, INC. holds 26.60K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $1.16M, representing 0.49% of its reported portfolio and ranking #24.
Has CONWAY CAPITAL MANAGEMENT, INC. been buying or selling BSX?
In the latest 13F filing (Q3 2026), CONWAY CAPITAL MANAGEMENT, INC. reduced its position in BSX. The position peaked in Q2 2025 at 29.64K shares.
Which other funds hold BSX?
Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS 投资管理, 德劭基金, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.